News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tepnel Life Sciences PLC (TED.L) Acquires Diaclone Research From OPi, SAS For $2.85 Million Cash



10/19/2005 5:11:20 PM

OPi SAS, a biopharmaceutical company developing products for rare diseases, said instrumentation and services company Tepnel Life Sciences PLC will acquire OPi's subsidiary Diaclone Research for EUR2.37 million ($2.85 million) in cash.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES